Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein for CVD Risk and Bone Density in Postmenopausal Women
NCT00000613Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 1997
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of genistein in cardiovascular diseases (CVD), osteoporosis, sponsored by National Heart, Lung, and Blood Institute. Started Apr 1997; status: completed.
02
Drugs
genistein
03
Conditions
cardiovascular diseases (CVD)osteoporosis
Beyond the preview
Go deeper on NCT00000613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000613.